Lumacaftor/ivacaftor will decrease the level or outcome of abemaciclib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Coadministration of abemaciclib with sturdy CYP3A4 inducers minimizes plasma focus of abemaciclib and its metabolites. duvelisib will raise the stage or effect of abemaciclib by influencing hepatic/intestinal enzyme https://tallentyrec332oyl5.wikimidpoint.com/user